Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence of dyslipidaemia in patients with renal cell carcinoma: a case-control study in China

Published:2014-03-14 Issue:5b Volume:113 Page:E75-E81
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Zhang Gui-Ming¹²,Zhu Yao¹²,Luo Lei³,Zhang Hai-Liang¹²,Gu Cheng-Yuan¹²,Sun Li-Jiang³,Ye Ding-Wei¹²

Affiliation:

1. Department of Urology; Fudan University Shanghai Cancer Center; Shanghai China

2. Department of Oncology; Shanghai Medical College; Fudan University; Shanghai China

3. Department of Urology; The Affiliated Hospital of Medical College; Qingdao University; Qingdao China

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12581/fullpdf

Reference26 articles.

1. Obesity and renal cell cancer-a quantitative review;Bergstrom;Br J Cancer,2001

2. Obesity, hypertension, and the risk of kidney cancer in men;Chow;N Engl J Med,2000

3. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study;Wulaningsih;J Cancer Epidemiol,2012

4. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan;Inoue;Eur J Cancer Prev,2009

5. Hypercholesterolemia and prostate cancer: a hospital-based case-control study;Magura;Cancer Causes Control,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of chronic viral hepatitis and metabolic factors on renal cancer risk in a large cohort in Republic of Korea;Preventive Medicine;2023-10

2. Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes;Nature Reviews Urology;2023-06-16

3. Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential;Frontiers in Oncology;2022-02-16

4. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target;Biomedicine & Pharmacotherapy;2022-02

5. LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway;Neoplasma;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3